Bajao, Veronica H.
HRN: 29-72-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2025
02/26/2025
IV
600mg
Every 8 Hours
DM Foot, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes